Cardiovascular Systems Inc
F:R7Y1
Fundamental Analysis

Revenue & Expenses Breakdown
Cardiovascular Systems Inc
Balance Sheet Decomposition
Cardiovascular Systems Inc
Current Assets | 222m |
Cash & Short-Term Investments | 132m |
Receivables | 40.2m |
Other Current Assets | 49.7m |
Non-Current Assets | 89.5m |
Long-Term Investments | 42m |
PP&E | 31.6m |
Intangibles | 15m |
Other Non-Current Assets | 831k |
Free Cash Flow Analysis
Cardiovascular Systems Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Cardiovascular Systems Inc
Revenue
|
239.8m
USD
|
Cost of Revenue
|
-66.2m
USD
|
Gross Profit
|
173.6m
USD
|
Operating Expenses
|
-212.2m
USD
|
Operating Income
|
-38.6m
USD
|
Other Expenses
|
695k
USD
|
Net Income
|
-37.9m
USD
|
R7Y1 Profitability Score
Profitability Due Diligence
Cardiovascular Systems Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Cardiovascular Systems Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
R7Y1 Solvency Score
Solvency Due Diligence
Cardiovascular Systems Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Score
Cardiovascular Systems Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
R7Y1 Price Targets Summary
Cardiovascular Systems Inc
Dividends
Current shareholder yield for R7Y1 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?